May 2024 updates to the website

The website has now been updated following May's LSCMMG

The following guidelines have been added/updated:

Amiodarone shared care - updated (this entry replaces the previous 'Amiodarone & Dronedarone' combined shared care)

Dronedarone shared care - updated (this entry replaces the previous 'Amiodarone & Dronedarone' combined shared care)

E-cigarette Position statement - updated

Gluten-free products position statement - updated

Antihistamine Position statement - updated

Insulin Toujeo information sheet and good practice guide - updated

Management of Psoriasis in Primary Care Guideline - updated

Constipation pathways - updated

Algorithm For Antihyperglycaemic Therapy in Adults with Type 2 Diabetes - updated

Axial spondyloarthritis pathway - updated

The following medicines have been added/updated following the latest Clinical Effectiveness Group (CEG) / Commissioning Resource Group (CRG) meeting:

Triptorelin - Central precocious puberty (onset before 8 years in girls and 10 years in boys) - added

Daridorexant - Treating long-term insomnia (NICE TA922) - added

Budesonide (targeted-release for primary IgA nephropathy) - Treating primary IgA nephropathy (NICE TA937) - added

Sucralfate (enema) - Radiation proctitis - added

Sucralfate (suspension and tablets) - Bile acid gastritis - added